Managing Hostile Stakeholders During the Launch of a Breakthrough New Medicine: Winning Patients to Your Side

Thus sometimes launch leaders must tread carefully to build credibility among patients and to respond to potential adversaries. Forward-looking pharma companies have started developing rapid response teams to map and engage the full range of hostile stakeholder groups.

Best Practices, LLC engaged senior launch leadership from pharma companies and conducted extensive secondary research to identify effective strategies for managing hostile stakeholders during the launch of a breakthrough new medicine.

The study probes key aspects including: turning citizens into political influencers; working with patient advocacy groups; and winning patients to your side.

KEY TOPICS

• Turning Citizens into Political Influencers
• Working with Patient Advocacy Groups
• Winning Patients on Your Side

• Find The Temperate Voices: Find moderate voices in special interest groups to gain footholds and build relationships.

• Arm Patients with Fact: Celebrity spokespeople can be a valuable channel by which to deliver education to patients who may not tune in to other healthcare outlets.

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.